Comparing Gamification With Remote Monitoring Against Standard Rehabilitation, for Patients After Arthroscopic Subacromial Decompression Surgery
Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Mar 9, 2016
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
Background:
Musculoskeletal problems are one of the most common reasons for seeking medical advice, with estimates of up to 20% of adults annually consulting their general practitioner. The prevalence of shoulder problems in the population is approximately 2.5%(Jordon et al 2010). In 2012/13, there were over 7.1 million outpatient appointments for trauma and orthopaedics in England (accounting for 9.3% of all outpatient attendances) and over 4 million of these visits were followup after the initial consultation (Hospital Episode Statistics). The average cost for each outpatient follow up i...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. A diagnosis of impingement syndrome based upon history, clinical examination and radiological findings that require arthroscopic subacromial decompression.
- • 2. The patient has access to the internet to allow for the remote monitoring element of the intervention.
- • 3. The patient needs to be able to use the sensor based technology safely, as judged by the research team.
- • 4. The patient is willing to consent to follow-up over a twelve month period.
- • 5. The patient has capacity to consent to the study.
- Exclusion Criteria:
- • 1. Aged less than 18 or greater than 70
- • 2. Patients who are unwilling or unable to consent
- • 3. Previous arthroscopic shoulder surgery
- • 4. Patients undergoing radiotherapy
- • 5. Patients with type 1 or type 2 diabetes
- • 6. Patients not fit for general anaesthetic
- • 7. Patients with significant cardiac dysfunction
- • 8. Uncontrolled hypertension
- • 9. Acute illness
- • 10. History of stroke / neuromuscular conditions preventing the use of Exergames
- • 11. Patient is currently enrolled in another clinical trial.
About Manchester University Nhs Foundation Trust
Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bolton, Lancashire, United Kingdom
Manchester, Lancashire, United Kingdom
Manchester, Lancashire, United Kingdom
Patients applied
Trial Officials
Bibhas Roy, MB CHB MSC
Principal Investigator
Central Manchester University Hospitals Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials